Factors influencing access to palliative radiotherapy: a Norwegian population-based study

References

• Cancer Registry of Norway. Cancer in Norway 2016 – cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway; 2017.
   Google Scholar
• Moller TR, Brorsson B, Ceberg J, et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol. 2003;42:387–410.
   PubMed Web of Science ®Google Scholar
• Åsli LM, Kvaløy SO, Jetne V, et al. Utilization of radiation therapy in Norway after the implementation of the national cancer plan: a national, population-based study. Int J Radiat Oncol Biol Phys. 2014;90:707.
   PubMed Web of Science ®Google Scholar
• Borras JM, Lievens Y, Barton M, et al. How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis. Radiother Oncol. 2016;119:5–11.
   PubMed Web of Science ®Google Scholar
• Lutz ST, Jones J, Chow E. Role of radiation therapy in palliative care of the patient with cancer. J Clin Oncol. 2014;32:2913–2919.
   PubMed Web of Science ®Google Scholar
• Cameron MG, Kersten C, Vistad I, et al. Palliative pelvic radiotherapy for symptomatic rectal cancer – a prospective multicenter study. Acta Oncol. 2016;55:1400–1407.
   PubMed Web of Science ®Google Scholar
• Cameron MG, Kersten C, Vistad I, et al. Palliative pelvic radiotherapy for symptomatic incurable prostate cancer – a prospective multicenter study. Radiother Oncol. 2015;115:314–320.
   PubMed Web of Science ®Google Scholar
• Lutz S, Balboni T, Jones J, et al. Palliative radiation therapy for bone metastases: update of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol. 2017;7:4–12.
   PubMed Web of Science ®Google Scholar
• Jacob S, Wong K, Delaney GP, et al. Estimation of an optimal utilisation rate for palliative radiotherapy in newly diagnosed cancer patients. Clin Oncol (R Coll Radiol). 2010;22:56–64.
   PubMed Web of Science ®Google Scholar
• Mackillop WJ, Kong W. Estimating the need for palliative radiation therapy: a benchmarking approach. Int J Radiat Oncol Biol Phys. 2016;94:51–59.
   PubMed Web of Science ®Google Scholar
• Huang J, Zhou S, Groome P, et al. Factors affecting the use of palliative radiotherapy in Ontario. Clin Oncol. 2001;19:137.
   Web of Science ®Google Scholar
• Lavergne MR, Johnston GM, Gao J, et al. Variation in the use of palliative radiotherapy at end of life: examining demographic, clinical, health service, and geographic factors in a population-based study. Palliat Med. 2011;25:101–110.
   PubMed Web of Science ®Google Scholar
• Murphy JD, Nelson LM, Chang DT, et al. Patterns of care in palliative radiotherapy: a population-based study. J Oncol Pract. 2013;9:e220–e227.
   PubMedGoogle Scholar
• Huang J, Wai ES, Lau F, et al. Palliative radiotherapy utilization for cancer patients at end of life in British Columbia: retrospective cohort study. BMC Palliat Care. 2014;13:49.
   PubMed Web of Science ®Google Scholar
• Nilssen Y, Strand TE, Fjellbirkeland L, et al. Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage. Int J Cancer. 2016;138:1350–1360.
   PubMed Web of Science ®Google Scholar
• Larsen IK, Smastuen M, Johannesen TB, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45:1218–1231.
   PubMed Web of Science ®Google Scholar
• Skyrud KD, Bray F, Moller B. A comparison of relative and cause-specific survival by cancer site, age and time since diagnosis. Int J Cancer. 2014;135:196–203.
   PubMed Web of Science ®Google Scholar
• Howlader N, Ries LA, Mariotto AB, et al. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst. 2010;102:1584–1598.
   PubMed Web of Science ®Google Scholar
• Mackillop WJ, Zhou S, Groome P, et al. Changes in the use of radiotherapy in Ontario 1984–1995. Int J Radiat Oncol Biol Phys. 1999;44:355–362.
   PubMed Web of Science ®Google Scholar
• Ministry of Health and Care Services. Omsorg og kunnskap! Norsk kreftplan. NOU 1997: 20 [Care and knowledge! The Norwegian Cancer Plan. NOU 1997: 20]. Oslo: Ministry of Health and Care Services; 1997.
   Google Scholar
• White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011;30:377–399.
   PubMed Web of Science ®Google Scholar
• StataCorp. Stata Statistical Software: Release 14. College Station (TX): StataCorp LP; 2015.
   Google Scholar
• Sutton DS, Kong W, Ding K, et al. The use of palliative radiotherapy for bone metastasis. Radiother Oncol. 2010;97:548–553.
   PubMed Web of Science ®Google Scholar
• Wong J, Xu B, Yeung HN, et al. Age disparity in palliative radiation therapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys. 2014;90:224–230.
   PubMed Web of Science ®Google Scholar
• Tyldesley S, Zhang-Salomons J, Groome PA, et al. Association between age and the utilization of radiotherapy in Ontario. Int J Radiat Oncol Biol Phys. 2000;47:469–480.
   PubMed Web of Science ®Google Scholar
• IPSOS MORI. Older people living with cancer. Exploring the attitudes and behaviours of older people living with cancer. London (UK): Macmillan Cancer Support; 2015. [Internet] Available from: http://www.macmillan.org.uk/Documents/Campaigns/AttitudesofolderpeoplelivingwithcancerAugust15.pdf
   Google Scholar
• Hanna TP, Richardson H, Peng Y, et al. A population-based study of factors affecting the use of radiotherapy for endometrial cancer. Clin Oncol (R Coll Radiol). 2012;24:e113–e124.
   PubMed Web of Science ®Google Scholar
• Tyldesley S, McGahan C. Utilisation of radiotherapy in rural and urban areas in British Columbia compared with evidence-based estimates of radiotherapy needs for patients with breast, prostate and lung cancer. Clin Oncol (R Coll Radiol). 2010;22:526–532.
   PubMed Web of Science ®Google Scholar
• Gabriel G, Barton M, Delaney GP. The effect of travel distance on radiotherapy utilization in NSW and ACT. Radiother Oncol. 2015;117:386–389.
   PubMed Web of Science ®Google Scholar
• Liu E, Santibanez P, Puterman ML, et al. A quantitative analysis of the relationship between radiation therapy use and travel time. Int J Radiat Oncol Biol Phys. 2015;93:710–718.
   PubMed Web of Science ®Google Scholar
• Vulto A, van Bommel M, Poortmans P, et al. General practitioners and referral for palliative radiotherapy: a population-based survey. Radiother Oncol. 2009;91:267–270.
   PubMed Web of Science ®Google Scholar
• Samant RS, Fitzgibbon E, Meng J, et al. Barriers to palliative radiotherapy referral: a Canadian perspective. Acta Oncol. 2007;46:659–663.
   PubMed Web of Science ®Google Scholar
• Sundaresan P, Milross CG, Smith A, et al. Factors influencing the use of RT in NSW: a qualitative study exploring consumer and health professional perspectives. J Med Imaging Radiat Oncol. 2014;58:625–632.
   PubMed Web of Science ®Google Scholar
• Laugsand TS, Kaasa S, Romundstad P, et al. Radiotherapy for bone metastases: practice in Norway 1997–2007. A national registry-based study. Acta Oncol. 2013;52:1129–1136.
   PubMed Web of Science ®Google Scholar
• Saito T, Toya R, Semba A, et al. Influence of the treatment schedule on the physicians' decisions to refer bone metastases patients for palliative radiotherapy: a questionnaire survey of physicians in various specialties. Nagoya J Med Sci. 2016;78:275–284.
   PubMed Web of Science ®Google Scholar
• Olsen AS, Ottesen S. Variable prescription of opioids to cancer patients in Norway. Tidsskr nor Laegeforen. 2008;128:1271–1274.
   PubMedGoogle Scholar
• Kong FM, Cuneo KC, Wang L, et al. Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation Oncology. Pract Radiat Oncol. 2014;4:e133–e141.
   PubMedGoogle Scholar